Cyclo Therapeutics Inc.

Address
6714 Northwest 16th Street

Sponsor Overview

assignment
2
sponsored trials
science
2
molecules
location_city
11
research centres
public
5
countries
person_search
10
investigators

Specializations

Neurodegenerative Disease Research

Cyclo Therapeutics Inc. focuses on clinical research in early Alzheimer’s disease, with attention to therapeutic options aimed at preserving cognitive function and addressing disease progression in the early stages of illness.

  • Alzheimer’s disease
  • Cognitive impairment
  • Neuroprotection

Its work in this area reflects interest in treatments designed for patients with early symptomatic neurodegeneration.

Rare Lysosomal Storage Disorder Research

The sponsor is also active in Niemann-Pick disease type C1, a rare inherited disorder associated with abnormal cholesterol transport and progressive neurological involvement.

  • Niemann-Pick disease type C1
  • Lysosomal storage disorder
  • Neurological progression

This therapeutic area includes interest in measures that track disease severity and functional change in patients with NPC1.

Intravenous Cyclodextrin Therapy

Clinical development activities include investigation of hydroxypropyl beta cyclodextrin as a treatment approach in both Alzheimer’s disease and NPC1, with emphasis on central nervous system-related therapeutic effects.

  • Hydroxypropyl beta cyclodextrin
  • Infusion-based therapy
  • Central nervous system disorders

These studies align with the sponsor’s interest in therapies for conditions involving neurological dysfunction and altered lipid handling.

Neurology and Rare Disease Clinical Development

The sponsor’s research portfolio spans neurology and rare disease therapeutics, with activity across multiple countries and collaborating research sites supporting patient access in specialized disease areas.

  • Neurology
  • Rare disease therapeutics
  • Specialty clinical research

Its medical interests center on conditions with limited treatment options, particularly disorders affecting cognition and progressive neurologic function.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 2 total (50% not shared with other sponsors)

This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 11 sites collaborated multiple times

This sponsor has worked with 11 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Genetic Phenomena1 trial
    26 other sponsors
  • 2.
    Nervous System Diseases1 trial
    449 other sponsors

Partnered Research Centres

11 centres
location_city
assignment392
Azienda Ospedaliera di Padova
Address
Via Nicolo' Giustiniani 2, 35128 Padua
Learn morearrow_forward
location_city
assignment300
Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania
Address
Via Santa Sofia 78, 95123 Catania
Learn morearrow_forward
location_city
assignment364
Bellvitge University Hospital
Address
Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Learn morearrow_forward
location_city
assignment772
Fondazione I.R.C.C.S. Istituto Neurologico Besta
Address
Via Giacomo Venezian 1, 20133 Milan
Learn morearrow_forward
location_city
assignment1357
Hospital Universitario 12 De Octubre
Address
Avenida De Cordoba Sn, 28041 Madrid
Learn morearrow_forward
location_city
assignment102
Instytut Pomnik Centrum Zdrowia Dziecka
Address
Aleja Dzieci Polskich 20, 04-730 Warsaw
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Cyclo Therapeutics Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.